Replies to post #514021 on NorthWest Biotherapeutics Inc (NWBO)

[Magrit]

Thanks Pgsd for restating the obvious for those who obviously don’t care that DCVAX works!

Good luck to patients, NWBO and investors who believe in the scientific facts about the DCVAX platform.

GLTU!

Margaret

[HyGro]

NWBO's trial was an interventional trial NOT Adaptive. From clinicaltrials.gov:
Study Type : Interventional (Clinical Trial)
It is NOT okay to totally redo the trial protocol and SAP after the trial has been completed.

NWBO press release on the data lock made NO statement about any protocol change. 5 months later, NWBO announced they were changing the protocol but didn't reveal how. It wasn't until the May 10th, 2022 TLD presentation at NYAS that they publicly announced the NEW protocol with the post hoc data dredged recurrent GBM arm.

[exwannabe]

YES it is, our trial was an adaptive trial

That has been said many times, but based on what?

An adaptive trial has the adaptive features designed in, This trial had one very minor adaptive feature, a BSSR resize that was never used.

All the other changes were just changes.